Home  >  Products  >  RHD (Rh blood group, D antigen ) Blocking Peptide (the N terminal of RHD)(100ug)
RHD (Rh blood group, D antigen ) Blocking Peptide (the N terminal of RHD)(100ug)

RHD (Rh blood group, D antigen ) Blocking Peptide (the N terminal of RHD)(100ug)

Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-RHD Antibody (ARP63086_P050), made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Reactivities: Human
Presku: AAP63086
Size: 100ug
Weight: 35kDa
Gene: The peptide is characterized by mass spectroscopy
Format: Lyophilized powder
Target: The Rh blood group system is the second most clinically significant of the blood groups, second only to ABO. It is also the most polymorphic of the blood groups, with variations due to deletions, gene conversions, and missense mutations. The Rh blood group includes this gene, which encodes the RhD protein, and a second gene that encodes both the RhC and RhE antigens on a single polypeptide. The two genes, and a third unrelated gene, are found in a cluster on chromosome 1. The classification of Rh-positive and Rh-negative individuals is determined by the presence or absence of the highly immunogenic RhD protein on the surface of erythrocytes. Multiple transcript variants encoding different isoforms have been found for this gene.
Alternative names: CD240D; DIIIc; MGC165007; RH; RH30; RHCED; RHDVA(TT); RHDel; RHPII; RHXIII; Rh4; RhDCw; RhII; RhK562-II; RhPI
See Full Product Listings >